Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of PEG ratio.
United Therapeutics UTHR has a PEG ratio of 1.19. United Therapeutics' trailing-twelve-month revenue is $1.12 billion.
Dr. Reddy's Laboratories RDY has a PEG ratio of 1.30. Dr. Reddy's trailing-twelve-month operating margin is 19.67%.
Taro Pharmaceutical Industries TARO has a PEG ratio of 1.23. Taro Pharmaceutical's trailing-twelve-month EPS is $7.14.
Endo Health Solutions ENDP has a PEG ratio 2.50. Endo Health's trailing-twelve-month ROA is 7.41%.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in